|
Post by BlueCat on Feb 1, 2017 20:08:12 GMT -5
According to the latest fails to deliver report, the total oustanding naked short shares on Jan 12 was 702 shares. Not 702 Million or 702K. 702 shares. I suspect that number will be significantly larger in 4 days. Then it will drop as shares are sourced. Dang. We used to have a high number. So basically, the shorts just hold on and don't bother covering because R/S is generally considered death knoll. They just have fewer shares held short. Unless as you say, they do start to pile on. That said, its the subsequent dilution that'll hurt more with this.
|
|
|
Post by gamblerjag on Feb 1, 2017 20:08:17 GMT -5
I think people set their hopes on Amgen to much.. I personally didn't think the connection of three current hires means a buyout or partnership. I was a little bummed about the r/s (just a little) but if it's in the interest of (just in case) i'm fine with that. Plus many r/s work out in the long run. And who knows the r/s might only be if the getting over $1 for 10 days or the 180 extension does workout. So until we see the actual result.. i'm not worried.. but did like that Matt eluded to the next month, or was it few weeks should be exciting (paraphrasing) is he expecting to announce something major?
|
|
|
Post by mnkdnewb on Feb 1, 2017 20:09:00 GMT -5
i want to know what happens to my 2018 options and the shorts after a reverse split? www.investopedia.com/ask/answers/05/shortsalesplits.aspNeither a long nor a short position is materially affected by a stock split - the value of the position does not change. So, if a company has announced that it will split in six months, it should have no bearing on the attractiveness of the short investment. The reason it is appealing for shorts now is because they know the company has no pending news for the next 6 months. All mnkd will do is burn cash and depreciate
|
|
|
Post by paaz77 on Feb 1, 2017 20:09:49 GMT -5
Man, I have to agree unfortunately. It appears that everyone is making money (management and shorts) except for long shareholders. I've learned a hard lesson the hard way.
I'm pre diabetic and currently taking 750mg ER metformin.
My endo has to be over 70 years old easily and when I ask if heard about Afrezza and if he would write a script, he told me that there's medicine for different cases and won’t write a script. That’s it, I’m calling one of the docs on the Afrezza friendly list and get my script when the new titration packs are available.
I’m pissed about the latest new and current/short term state of the company but not that pissed not to get better medically. I’m doing my part financially and medically to help Afrezza stay on the market.
|
|
|
Post by mnkdfann on Feb 1, 2017 20:12:29 GMT -5
Finally home from work and I can listen to today's archived CC! Unfortunately, I have an idea of what to expect to hear.
|
|
|
Post by LosingMyBullishness on Feb 1, 2017 20:25:30 GMT -5
Folks, just listened to the call and and have been following the threads. Have to say this is the first time I've had a fairly major disconnect between my thinking and the 'flow' on this board. The general consensus seems to be pretty negative. I dont see it. It was a housekeeping call announcing the set up for a possible RS. Did anyone seriously investing in this company for some time not see this coming? I dont get all the negativity this evening - unless it is residual scar tissue from the decline in the last year. Which is fair enough , I sure have my bumps. But so what.. we have a little bit of cash.. and sales force with real skin in the game, beginnings of movement on the payers and finally a focus on T2. All in? probably not for me. But the insulin business is huge and Afrezza is at least as good as any injectable. Mblowes: the negativity is IMO because it had been bad news for more than 18 months. And still, 12 months after MNKD management knows that they have to get things done ASAP and all by themselves, they still seem rather clueless. Little of importance had been achieved. Some are okay with the little things and that's okay if you believe that they will one day succeed. But one day means dead money for an unknown period of time and eventually again dilution. The effect of dead money is often underestimated.
|
|
|
Post by falconquest on Feb 1, 2017 20:25:33 GMT -5
i want to know what happens to my 2018 options and the shorts after a reverse split? www.investopedia.com/ask/answers/05/shortsalesplits.aspNeither a long nor a short position is materially affected by a stock split - the value of the position does not change. So, if a company has announced that it will split in six months, it should have no bearing on the attractiveness of the short investment. Ok, you keep telling yourself that. Everything will be fine.....nothing to see here, just keep moving.
|
|
|
Post by wgreystone on Feb 1, 2017 20:29:25 GMT -5
"Which is better? Owning 50k shares and the stock going up $1 or owning 5k shares after the split and the stock going up $1? There's why there split limits your upside. Those underwater now will likely never be made whole again." Would you rather own a $100 bill or five $20 bills? It is the same thing. There is no additional limit to the upside. Or the downside. To some extent, RS may help attracting new buyers. Many funds are restricted to buy stocks under $5. My 401K does not allow me to buy stock under $1. Once RS happens, I can surely buy more in my 401K account.
|
|
|
Post by gamblerjag on Feb 1, 2017 20:32:13 GMT -5
i do like that Matt said we are doing this possible R/S out of strenght not weakness like some Companies.
|
|
|
Post by dreamboatcruise on Feb 1, 2017 20:36:20 GMT -5
Why even have this conference call at all we had a better chance of getting over a dollar if they stayed quite. Is Matt deliberately doing this? We're not getting over a dollar without some significant "development" that garners funding. Anyone can see that without funding the script growth isn't going to move the share price in the time frame needed. The reason Matt did the call was merely to try to put a good spin on it and provide warning for the small group of retail investors that might not have realized the impending need for RS. This news isn't surprising Wall Street. For most investors having this sort of call ahead of time increases confidence (a little), rather than decreasing. Simply putting out the proxy at the last moment and saying nothing would be very destructive of investor confidence.
|
|
|
Post by sportsrancho on Feb 1, 2017 20:39:29 GMT -5
MNKD was trading at 11$ a share not that long ago.. yes it was overvalued and perhaps went there on momentum.. but I cannot see this stock trading at 110$ a share any time soon... I don't know what it is... psychology perhaps once the stock price gets that high?? The same psychology that scares the hell out of people when there is a RS ... I cant explain it... because in fact you are correct.. but things do change after a RS .. If Matt and Mike thought they had a lot to prove before..... they most certainly do now.. I still believe they have done a good job with the hand they have been dealt.. I think they've been walking on egg shells for some time having to be very careful about everything they say.. cuz any hint of doubt could send the share price tumbling and they were trying so hard to avoid this.. they are both good guys who believe in Afrezza... I can see why reverselo critizises the feelings that many here put into this stock. Sweedee, a price of a share is meaningless (as long as it is not so low that these shares are not traded by certain funds). This psychology is what makes some retailers buy or sell a stock. Most of the time this is a bad decision. The market is cool and it decided that Matt, Mike and all the others we do not see did a terrible job, literally. I do not see what Ken Kresa and the other guys at the board are doing beside getting paid for it. And I wonder what Ray and Joseph are really busy with. I find it very important that these people are good guys but it is also important that they deliver. They get money for what they are doing. Reverselo has no business critizicing anyone for anything!
|
|
|
Post by agedhippie on Feb 1, 2017 20:44:49 GMT -5
Man, I have to agree unfortunately. It appears that everyone is making money (management and shorts) except for long shareholders. I've learned a hard lesson the hard way. I'm pre diabetic and currently taking 750mg ER metformin. My endo has to be over 70 years old easily and when I ask if heard about Afrezza and if he would write a script, he told me that there's medicine for different cases and won’t write a script. That’s it, I’m calling one of the docs on the Afrezza friendly list and get my script when the new titration packs are available. I’m pissed about the latest new and current/short term state of the company but not that pissed not to get better medically. I’m doing my part financially and medically to help Afrezza stay on the market. If you are pre-diabetic and on metformin there is no way you should be on insulin. There are Type 1 diabetics (me included) who would give their eye teeth to get off insulin and be able to use just metformin. My advice is to enjoy it while you can. Sorry if I sound a little bitter.
|
|
|
Post by dreamboatcruise on Feb 1, 2017 20:45:25 GMT -5
I have spoken to one of the regional managers recently and I can tell you he is extremely enthusiastic about the future of Afrezza, MannKind and Michael. Is he biased? Of course he is but the tone in his voice sounded sincere. Additionally, tone of voice might be something where one's own bias might influence perception. Would be much better if there were some concrete information indicating a meaningful change in script trajectory is coming.
|
|
|
Post by agedhippie on Feb 1, 2017 20:45:36 GMT -5
i do like that Matt said we are doing this possible R/S out of strenght not weakness like some Companies. So did I, that was hysterical
|
|
|
Post by alethea on Feb 1, 2017 20:51:45 GMT -5
i do like that Matt said we are doing this possible R/S out of strenght not weakness like some Companies. And you believe that?
|
|